These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 861080)

  • 1. [Evaluation of biologic availability of active principles contained in galenic forms for cutaneous administration].
    Aiache JM; Aiache S; Guilpain G; Paire M
    Boll Chim Farm; 1977 Feb; 116(2):63-80. PubMed ID: 861080
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings: Topical availability of hydrocortisone from different ointment bases.
    Ritschel WA; Kitzmiller KW; Serracino-Inglott A
    Rev Can Biol; 1973; 32():Suppl:91-7. PubMed ID: 4777607
    [No Abstract]   [Full Text] [Related]  

  • 3. Factors influencing the formulation of semisolid preparations with special reference to corticosteroid products.
    Worthington HE
    Acta Derm Venereol Suppl (Stockh); 1973; 53():29-34. PubMed ID: 4518660
    [No Abstract]   [Full Text] [Related]  

  • 4. [Topical pharmaceutical forms].
    Zerrouk N; Arnaud P
    Ann Dermatol Venereol; 2007 Mar; 134(3 Pt 2):2S24-6. PubMed ID: 17563710
    [No Abstract]   [Full Text] [Related]  

  • 5. [Some data on external therapy of dermatoses].
    Ormea TF
    Minerva Med; 1973 Oct; 64(77):4021-8. PubMed ID: 4764073
    [No Abstract]   [Full Text] [Related]  

  • 6. Topical product design and extemporaneous compounding in dermatology.
    Krochmal L; Patel B
    Adv Dermatol; 1992; 7():231-52; discussion 253. PubMed ID: 1739582
    [No Abstract]   [Full Text] [Related]  

  • 7. [The history of dosage form from the German Pharmacopoeia I to II of East Germany].
    Heise HG; Heise J
    Pharmazie; 1984 Jul; 39(7):445-61. PubMed ID: 6494224
    [No Abstract]   [Full Text] [Related]  

  • 8. [Influence of dosage form on drug effect].
    Zathurecký L
    Pharmazie; 1972 Nov; 27(11):686-93. PubMed ID: 4650983
    [No Abstract]   [Full Text] [Related]  

  • 9. [Measurement of the biologic-availability of an active principle applied topically].
    Gumma A
    Pharm Acta Helv; 1971 Dec; 46(12):730-6. PubMed ID: 5143004
    [No Abstract]   [Full Text] [Related]  

  • 10. [Stages of the development of the science of the production of drugs and galenic preparations].
    Murav'ev IA
    Farmatsiia; 1967; 16(5):19-33. PubMed ID: 4888789
    [No Abstract]   [Full Text] [Related]  

  • 11. [Approach to the technologic and biopharmaceutic evaluation of dermatological preparations].
    Curcio L; Rigamonti S
    Boll Chim Farm; 1971 Aug; 110(8):421-7. PubMed ID: 5137980
    [No Abstract]   [Full Text] [Related]  

  • 12. [MECHANISM AND NORM OF THE PHYSICAL THERMO-EFFECT OF DERMATOLOGICAL EXTERNAL AGENTS].
    KLEINE-NATROP HE
    Dermatol Wochenschr; 1963 Jan; 147():81-93. PubMed ID: 14172115
    [No Abstract]   [Full Text] [Related]  

  • 13. [Biopharmaceutical evaluation of hydrocortisone acetate ointment applied to the skin].
    Umer S
    Acta Pol Pharm; 1984; 41(3):375-80. PubMed ID: 6524403
    [No Abstract]   [Full Text] [Related]  

  • 14. [Dermatological externals, particularly their releasing capacity].
    Hagerman G
    Z Haut Geschlechtskr; 1973 Feb; 48(3):97-105. PubMed ID: 4266852
    [No Abstract]   [Full Text] [Related]  

  • 15. [Biologic availability as a function of the pharmaceutic form].
    Cardini C; Mazzaracchio F; Quercia V
    Boll Chim Farm; 1974 Aug; 113(8):455-7. PubMed ID: 4433431
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative pharmacokinetics and bioavailability study of percutaneous absorption of diclofenac from two topical formulations containing drug as a solution gel or as an emulsion gel.
    Seth BL
    Arzneimittelforschung; 1992 Feb; 42(2):120-2. PubMed ID: 1610419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biological and in vitro availability].
    Speiser P
    Pharm Acta Helv; 1971 Aug; 46(8):449-67. PubMed ID: 5092965
    [No Abstract]   [Full Text] [Related]  

  • 18. [Advances in pharmaceutical technology in 1966-1967. II. Drugs and pharmaceutical preparations].
    Chalabala M; Malý J; Burelová A; Starha L; Heliová M; Rak J; Rehula A
    Cesk Farm; 1968 Nov; 17(9):450-61. PubMed ID: 4888356
    [No Abstract]   [Full Text] [Related]  

  • 19. Biopharmaceutical aspects of the design of steroidal dosage forms.
    Short MP; Rhodes CT
    Pharmazie; 1973 Aug; 28(8):509-13. PubMed ID: 4593892
    [No Abstract]   [Full Text] [Related]  

  • 20. [Advances in the field of galenics (1965 to 1967)].
    Chalabala M; Malý J; Burelová A
    Pharmazie; 1969 Feb; 24(2):65-86. PubMed ID: 4891843
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.